Article Media
CONTACT: communications@aclusocal.org, (213) 977-5252
LOS ANGELES - Today, the U.S. Supreme Court ruled in U.S. v. Skrmetti, a challenge brought by three transgender adolescents, their families, and a Memphis-based medical provider against a Tennessee law banning gender-affirming hormone therapies for transgender people under 18.
The court held that Tennessee’s SB1 does not draw a sex-based (or a trans status-based) line and accepted Tennessee’s purported justifications for its ban. The ruling will allow SB1 to remain in effect.
In response, Amanda Goad, the Audrey Irmas director of the Gender, Sexuality, and Reproductive Justice Project at the ACLU Foundation of Southern California, issued the following statement on behalf of the ACLU affiliates in California:
“Though today’s decision is devastating for trans people across the country, California law still protects the rights of trans youth to access the care they need.
Trans young people thrive when we all build a gender-affirming future they can see themselves in. The attacks on essential health care for trans young people are part of an attempt to erase scapegoated communities from public life. Families, doctors, and patients deserve trust, respect, and privacy as they make medical decisions without political interference. We will continue to support and help strengthen the California laws and policies that affirm trans young people’s right to be authentically themselves.”
